REQUEST A DEMO
Total
USD $0.00
Search more companies

Galaxis Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Galaxis Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English Download a sample report

Galaxis Pharma Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kuala Lumpur. The company operates in the Pharmacies and Drug Stores industry. Galaxis Pharma Sdn. Bhd. was incorporated on August 24, 2018. From the latest financial highlights, Galaxis Pharma Sdn. Bhd. reported a net sales revenue drop of 9.41% in 2023. There was a total growth of 25.64% in Galaxis Pharma Sdn. Bhd.’s total assets over the same period. In 2023, Galaxis Pharma Sdn. Bhd.’s net profit margin decreased by 7.47%.

Headquarters
No.22G, Vista Magna, Block B, Metro Prima, Kepong
Kuala Lumpur; Federal Territories; Postal Code: 52100

Contact Details: Purchase the Galaxis Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Galaxis Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Galaxis Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
August 24, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Galaxis Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-9.41%
Total operating revenue
-9.41%
Operating profit (EBIT)
-98.36%
EBITDA
-98.05%
Net Profit (Loss) for the Period
-98.55%
Total assets
25.64%
Total equity
109.64%
Operating Profit Margin (ROS)
-9.02%
Net Profit Margin
-7.47%
Return on Equity (ROE)
-102.67%
Quick Ratio
0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?